Beryl Drugs Ltd Share Price

₹23.20 -0.79 (-3.29%) BSE
as updated on 24-Dec-2025 16:59 | Sector - Healthcare

Day Range

  • Day's Low:23.20
  • Day's High:23.99

  • 52 Week Low17.35
  • 52 Week High43.70

Beryl Drugs Ltd's key Fundamentals

Market Cap ₹12 Cr.
P/E Ratio 52
TTM EPS 0.5
P/B Ratio 1.29
ROE 6.28
Debt to Equity 0.43
Face Value 10
BVPS 18.6
3 Year Sales Growth 13.15%

Beryl Drugs Ltd's Share Price Returns

1 Day -3.29%
1 Week 0.90%
1 Month 0.40%
3 Months -2.30%
6 Months 14.40%
1 Years -34.50%
3 Years 98.30%
5 Years 212.20%
10 Years 0%

Financial Ratio Analysis

Adj EPS (Rs.)
Sales (Cr.)
ROE (%)
ROCE (%)

Check our DeciZen before investing

Check Stock Quality
Check Stock Valuation
Check Price Trend

Beryl Drugs Ltd Shareholding Pattern

Promoters

(26.38%)

Institutions

(0.00%)

Non-Institutions

(73.62%)

Pledged shares as % of Promoter's holding (%)

(0.00%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Balance Sheet

(All Figures are in Crores.)

Profit And Loss

(All Figures in Cr. Adjusted EPS in Rs.)

Cash Flow

(All Figures are in Crores.)

About Beryl Drugs Ltd

Beryl Drugs incorporated in 1993 is into manufacturing and marketing of branded, generic pharmaceutical formulations. The company is one of leading manufacturer of I.V.fluids and small volume injectables.

Beryl has emerged into a global network of pharmaceutical manufacturing, research and development, contract manufacturing services and veterinary products. 

The manufacturing facilities of the company are in compliance with WHO GMP specifications.

Company owns brands like BERI-CEF injection, F-Neuron, Amplicillin INJ, P-Mol, Biprox, B-Flox and many more.

The shares of Beryl Drugs are listed on M.P. Stock Exchange, Bombay Stock Exchange and Ahmedabad Stock Exchange.

Products manufactured by the company:

  • Small volume injectables in liquid form
  • Small volume injectables in dry powder form
  • Variety of eye and ear drops
  • I.V.Fluids in polypack and glass bottles
  • Variety of vetrinary medicines

Award/recognition

The company has received ISO 9001:2000 certification for its quality management.

Read More Read Less
Read More Read Less

Investment related blogs

Day Range

  • Day's Low: 23.20
  • Day's High: 23.99

  • 52 Week Low17.35
  • 52 Week High43.70

Beryl Drugs Ltd's key Fundamentals

Market Cap ₹12 Cr.
P/E Ratio 52
TTM EPS 0.5
P/B Ratio 1.29
ROE 6.28
Debt to Equity 0.43
Face Value 10
BVPS 18.6
3 Year Sales Growth 13.15%

Beryl Drugs Ltd's Share Price Returns

1 Day -3.29%
1 Week 0.90%
1 Month 0.40%
3 Months -2.30%
6 Months 14.40%
1 Years -34.50%
3 Years 98.30%
5 Years 212.20%
10 Years 0%

Investment related blogs

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×